Inhibrx Biosciences, Inc.

INBX

INBXInhibrx Biosciences, Inc. US flag

NASDAQ Global Market

95.22

USD

+1.59

- -

1.40BMarket Cap

Profitability (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -
Return on Assets (%)	- -	-148.74	690.69	-85.6
Return on Capital (%)	- -	- -	-678.16	- -
Return on Invested Capital (%)	- -	- -	-167.7	- -
Gross Margin (%)	100	100	100	100
EBITDA Margin (%)	-8,770.02	-12,112.78	-164,581.5	-10,195.54
Operating Margin (%)	-8,864.18	-12,178.94	-165,724	-10,386.54
Incremental Operating Margin (%)	- -	- -	- -	- -
Pretax Margin (%)	-8,864.1	-13,318	843,787	-10,773.31
Profit Margin (%)	-8,864.34	-13,408.94	843,786	-10,773.46
Net Income to Common Margin (%)	-8,864.34	-13,408.94	843,786	-10,773.46
Effective Tax Rate (%)	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -

Credit (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	5	210	8	107
ST Debt	2	2	2	2
LT Debt	3	208	6	105
Total Debt/EBITDA	-0.04	-0.96	-0.02	-0.81
Net Debt/EBITDA	- -	0.33	0.46	0.18
Total Debt/EBIT	-0.04	-0.96	-0.02	-0.79
Net Debt/EBIT	- -	0.32	0.46	0.18
EBITDA to Interest Expense	- -	-6.85	-24.4	-10.87
EBITDA-CapEx/Interest Expense	- -	-6.99	-24.59	-10.87
EBIT to Interest Expense	- -	-6.89	-24.57	-11.07
Interest Expense	- -	32	13	12
Common Equity/Total Assets	- -	-199.33	-58.71	-168.07
Long-Term Debt/Equity (%)	- -	478.31	4.83	1,309.72
Long-Term Debt/Capital (%)	63.04	-51.56	-6.58	-75.22
Long-Term Debt/Total Assets (%)	19.06	67.58	3.57	71.47
Total Debt/Equity (%)	-68.95	483.05	6.02	1,338.82
Total Debt/Capital (%)	100	-52.07	-8.21	-76.89
Total Debt/Total Assets (%)	30.24	68.25	4.45	73.06
Net Debt to Equity	- -	-163.11	-114.23	-296.02
Net Debt/Capital (%)	- -	10.41	60.87	8.98
EBITDA	-114	-218	-329	-133
EBITDA-CapEx	-115	-223	-332	-133
Operating Income (Loss)	-115	-219	-331	-135

Liquidity (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	- -	4.94	3.75	3.68
Current Ratio	0.3	5.25	3.94	3.93
Quick Ratio	0.01	4.95	3.76	3.68
CFO/Avg Current Liab	- -	-5.02	-4.01	-3.48
Common Equity/Total Assets	- -	-199.33	-58.71	-168.07
Long-Term Debt/Equity (%)	- -	478.31	4.83	1,309.72
Long-Term Debt/Capital (%)	63.04	-51.56	-6.58	-75.22
Long-Term Debt/Total Assets (%)	19.06	67.58	3.57	71.47
Total Debt/Equity (%)	-68.95	483.05	6.02	1,338.82
Total Debt/Capital (%)	100	-52.07	-8.21	-76.89
Total Debt/Total Assets (%)	30.24	68.25	4.45	73.06
CFO/Total Liabilities	-379.25	-73.12	-412.03	-93.72
CFO/CapEx	-132.38	-42.09	-74.86	-4,186.9
Altman's Z-Score	-15.04	-2.97	-3.18	0.73

Working Capital (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	3.53	0.41	13
Days Sales Outstanding	- -	103.52	892.42	28.08
Inventory Turnover	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -
Inventories	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	351	541	228	1,223
- Cash & Cash Equivalents	- -	278	153	124
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -
+ Total Debt	5	210	8	107
Enterprise Value	356	473	83	1,206
Total Capital	5	-404	-98	-139
Total Debt/Capital (%)	100	-52.07	-8.21	-76.89
Total Debt / EV	0.01	0.44	0.1	0.09
EV/Sales	273.59	262.99	417.01	927.9
EV/EBITDA	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -
Diluted Market Cap	351	541	231	1,223
Diluted Enterprise Value	356	473	86	1,206
EV per Share	24.99	33.24	5.63	77.89
TTM Sales	1	2	- -	1
TTM EBITDA	-114	-218	-329	-133
TTM Operating Income	-115	-219	-331	-135
TTM Cash Flow to Firm	-91	-161	-181	-118
TTM Free Cash Flow to Firm	-90	-157	-178	-118

Multiples (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	-3.89	-2.87	-1.2	-9.43
EV/EBIT	- -	- -	- -	- -
Enterprise Value	356	473	83	1,206
Low Price	7.67	14.31	10.8	10.81
EV/Sales	273.59	262.99	417.01	927.9
EV/EBITDA	- -	- -	- -	- -
Price/Earnings	- -	- -	0.14	- -
Price/Earnings Average	-2.71	-1.31	0.2	-3.34
Price/Earnings High	-5.47	-2.33	0.35	-10.46
Price/Earnings Low	-0.95	-0.84	0.09	-1.2
Price/Book Value	- -	-0.88	-2.15	-4.97
Price/Book Value Average	- -	-0.52	-3.26	-1.9
Price/Book Value High	- -	-0.92	-5.55	-5.95
Price/Book Value Low	- -	-0.33	-1.51	-0.68
Price/Tangible Book Value	-48.07	12.44	1.71	153.07
Price/Tangible Book Value Average	-42.75	7.28	2.59	58.53
Price/Tangible Book Value High	-86.46	12.93	4.41	183.24
Price/Tangible Book Value Low	-14.96	4.68	1.2	20.95
Price/Sales	269.72	300.65	1,139.75	941.13
Price/Sales Average	239.88	175.89	1,728.13	359.89
Price/Sales High	485.14	312.51	2,944.86	1,126.62
Price/Sales Low	83.96	113.22	799.31	128.78
Price/Cash Flow	-3.86	-2.8	-1.17	-9.43
Price/Cash Flow Average	-3.44	-1.64	-1.78	-3.6
Price/Cash Flow High	-6.95	-2.91	-3.03	-11.28
Price/Cash Flow Low	-1.2	-1.05	-0.82	-1.29
Price/Free Cash Flow Average	-3.46	-1.68	-1.82	-3.61
Price/Free Cash Flow High	-7	-2.98	-3.11	-11.29
Price/Free Cash Flow Low	-1.21	-1.08	-0.84	-1.29
EV/Sales Average	243.75	138.24	1,005.39	346.65
EV/Sales High	489.01	274.86	2,222.12	1,113.38
EV/Sales Low	87.83	75.56	76.57	115.54
EV/EBITDA Average	-2.78	-1.14	-0.61	-3.4
EV/EBITDA High	-5.58	-2.27	-1.35	-10.92
EV/EBITDA Low	-1	-0.62	-0.05	-1.13
EV/EBIT Average	-2.75	-1.14	-0.61	-3.34
EV/EBIT High	-5.52	-2.26	-1.34	-10.72
EV/EBIT Low	-0.99	-0.62	-0.05	-1.11
Last Price	24.64	38	15.4	79
High Price	44.32	39.5	39.79	94.57
Enterprise Value Average	317	249	201	451
Enterprise Value High	636	495	444	1,447
Enterprise Value Low	114	136	15	150

Profitability (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -
Return on Assets (%)	- -	-148.74	690.69	-85.6
Return on Capital (%)	- -	- -	-678.16	- -
Return on Invested Capital (%)	- -	- -	-167.7	- -
Gross Margin (%)	100	100	100	100
EBITDA Margin (%)	-8,770.02	-12,112.78	-164,581.5	-10,195.54
Operating Margin (%)	-8,864.18	-12,178.94	-165,724	-10,386.54
Incremental Operating Margin (%)	- -	- -	- -	- -
Pretax Margin (%)	-8,864.1	-13,318	843,787	-10,773.31
Profit Margin (%)	-8,864.34	-13,408.94	843,786	-10,773.46
Net Income to Common Margin (%)	-8,864.34	-13,408.94	843,786	-10,773.46
Effective Tax Rate (%)	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -

Credit (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	5	210	8	107
ST Debt	2	2	2	2
LT Debt	3	208	6	105
Total Debt/EBITDA	-0.04	-0.96	-0.02	-0.81
Net Debt/EBITDA	- -	0.33	0.46	0.18
Total Debt/EBIT	-0.04	-0.96	-0.02	-0.79
Net Debt/EBIT	- -	0.32	0.46	0.18
EBITDA to Interest Expense	- -	-6.85	-24.4	-10.87
EBITDA-CapEx/Interest Expense	- -	-6.99	-24.59	-10.87
EBIT to Interest Expense	- -	-6.89	-24.57	-11.07
Interest Expense	- -	32	13	12
Common Equity/Total Assets	- -	-199.33	-58.71	-168.07
Long-Term Debt/Equity (%)	- -	478.31	4.83	1,309.72
Long-Term Debt/Capital (%)	63.04	-51.56	-6.58	-75.22
Long-Term Debt/Total Assets (%)	19.06	67.58	3.57	71.47
Total Debt/Equity (%)	-68.95	483.05	6.02	1,338.82
Total Debt/Capital (%)	100	-52.07	-8.21	-76.89
Total Debt/Total Assets (%)	30.24	68.25	4.45	73.06
Net Debt to Equity	- -	-163.11	-114.23	-296.02
Net Debt/Capital (%)	- -	10.41	60.87	8.98
EBITDA	-114	-218	-329	-133
EBITDA-CapEx	-115	-223	-332	-133
Operating Income (Loss)	-115	-219	-331	-135

Liquidity (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	- -	4.94	3.75	3.68
Current Ratio	0.3	5.25	3.94	3.93
Quick Ratio	0.01	4.95	3.76	3.68
CFO/Avg Current Liab	- -	-5.02	-4.01	-3.48
Common Equity/Total Assets	- -	-199.33	-58.71	-168.07
Long-Term Debt/Equity (%)	- -	478.31	4.83	1,309.72
Long-Term Debt/Capital (%)	63.04	-51.56	-6.58	-75.22
Long-Term Debt/Total Assets (%)	19.06	67.58	3.57	71.47
Total Debt/Equity (%)	-68.95	483.05	6.02	1,338.82
Total Debt/Capital (%)	100	-52.07	-8.21	-76.89
Total Debt/Total Assets (%)	30.24	68.25	4.45	73.06
CFO/Total Liabilities	-379.25	-73.12	-412.03	-93.72
CFO/CapEx	-132.38	-42.09	-74.86	-4,186.9
Altman's Z-Score	-15.04	-2.97	-3.18	0.73

Working Capital (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	3.53	0.41	13
Days Sales Outstanding	- -	103.52	892.42	28.08
Inventory Turnover	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -
Inventories	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	351	541	228	1,223
- Cash & Cash Equivalents	- -	278	153	124
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -
+ Total Debt	5	210	8	107
Enterprise Value	356	473	83	1,206
Total Capital	5	-404	-98	-139
Total Debt/Capital (%)	100	-52.07	-8.21	-76.89
Total Debt / EV	0.01	0.44	0.1	0.09
EV/Sales	273.59	262.99	417.01	927.9
EV/EBITDA	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -
Diluted Market Cap	351	541	231	1,223
Diluted Enterprise Value	356	473	86	1,206
EV per Share	24.99	33.24	5.63	77.89
TTM Sales	1	2	- -	1
TTM EBITDA	-114	-218	-329	-133
TTM Operating Income	-115	-219	-331	-135
TTM Cash Flow to Firm	-91	-161	-181	-118
TTM Free Cash Flow to Firm	-90	-157	-178	-118

Multiples (USD)

API Chat

	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	-3.89	-2.87	-1.2	-9.43
EV/EBIT	- -	- -	- -	- -
Enterprise Value	356	473	83	1,206
Low Price	7.67	14.31	10.8	10.81
EV/Sales	273.59	262.99	417.01	927.9
EV/EBITDA	- -	- -	- -	- -
Price/Earnings	- -	- -	0.14	- -
Price/Earnings Average	-2.71	-1.31	0.2	-3.34
Price/Earnings High	-5.47	-2.33	0.35	-10.46
Price/Earnings Low	-0.95	-0.84	0.09	-1.2
Price/Book Value	- -	-0.88	-2.15	-4.97
Price/Book Value Average	- -	-0.52	-3.26	-1.9
Price/Book Value High	- -	-0.92	-5.55	-5.95
Price/Book Value Low	- -	-0.33	-1.51	-0.68
Price/Tangible Book Value	-48.07	12.44	1.71	153.07
Price/Tangible Book Value Average	-42.75	7.28	2.59	58.53
Price/Tangible Book Value High	-86.46	12.93	4.41	183.24
Price/Tangible Book Value Low	-14.96	4.68	1.2	20.95
Price/Sales	269.72	300.65	1,139.75	941.13
Price/Sales Average	239.88	175.89	1,728.13	359.89
Price/Sales High	485.14	312.51	2,944.86	1,126.62
Price/Sales Low	83.96	113.22	799.31	128.78
Price/Cash Flow	-3.86	-2.8	-1.17	-9.43
Price/Cash Flow Average	-3.44	-1.64	-1.78	-3.6
Price/Cash Flow High	-6.95	-2.91	-3.03	-11.28
Price/Cash Flow Low	-1.2	-1.05	-0.82	-1.29
Price/Free Cash Flow Average	-3.46	-1.68	-1.82	-3.61
Price/Free Cash Flow High	-7	-2.98	-3.11	-11.29
Price/Free Cash Flow Low	-1.21	-1.08	-0.84	-1.29
EV/Sales Average	243.75	138.24	1,005.39	346.65
EV/Sales High	489.01	274.86	2,222.12	1,113.38
EV/Sales Low	87.83	75.56	76.57	115.54
EV/EBITDA Average	-2.78	-1.14	-0.61	-3.4
EV/EBITDA High	-5.58	-2.27	-1.35	-10.92
EV/EBITDA Low	-1	-0.62	-0.05	-1.13
EV/EBIT Average	-2.75	-1.14	-0.61	-3.34
EV/EBIT High	-5.52	-2.26	-1.34	-10.72
EV/EBIT Low	-0.99	-0.62	-0.05	-1.11
Last Price	24.64	38	15.4	79
High Price	44.32	39.5	39.79	94.57
Enterprise Value Average	317	249	201	451
Enterprise Value High	636	495	444	1,447
Enterprise Value Low	114	136	15	150

	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	14	14	14	15
Diluted Weighted Avg Shares	14	14	15	15
Basic Weighted Avg Shares	14	14	15	15
Revenue per Share	0.09	0.13	0.01	0.08
EBITDA per Share	-8.01	-15.31	-22.24	-8.56
Operating Income per Share	-8.1	-15.39	-22.39	-8.72
Basic EPS, GAAP	-8.1	-16.95	114.01	-9.04
Basic EPS from Cont Ops	-8.1	-16.95	114.01	-9.04
Diluted EPS, GAAP	-8.1	-16.95	112.62	-9.04
Diluted EPS from Cont Ops	-8.1	-16.95	112.62	-9.04
Dividend per Share	- -	- -	- -	- -
Cash Flow per Share	-6.38	-13.57	-13.13	-8.38
Free Cash Flow per Basic Share	-6.42	-13.9	-13.31	-8.38
Cash & Equivalents per Share	- -	19.52	10.31	8.02
Book Value per Share	- -	-43.1	-7.17	-15.9
Tangible Book Value per Share	-0.51	3.05	9.02	0.52

Inhibrx Biosciences, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)